Moreover, the present model has been previously validated and indicates a significant trend towards cost reductions and a decreased duration of sick leave following the specific incorporation of effective targeted therapies.
← all excerpts
Analysis of the Reduction in the Duration of Sick Leave for 32,512 Psoriasis Patients Following the Integration of Targeted Therapies for Psoriatic Disease into the Brazilian Healthcare System: a Retrospective Cohort Study.
1
—
—